Transaction in Own Shares
Summary by AI BETAClose X
|
NatWest Group plc |
|
|
|
|
|
|
31 July 2026 |
|
|
|
|
|
|
Transaction in Own Shares |
|
|
|
|
|
|
NatWest Group plc (the 'Company') announces that, over the past week, it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS'). |
|||||
|
|
|
|
|
|
|
|
Aggregated information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of purchase |
Number of Ordinary Shares purchased |
Highest price paid: (GBp) |
Lowest price paid: (GBp) |
Volume weighted average price paid per share (GBp) |
Venue |
|
28 July 2026 |
1,629,007 |
680.0000 |
660.00 |
666.8981 |
LSE |
|
28 July 2026 |
422,597 |
675.2000 |
660.00 |
666.8703 |
CHIX |
|
28 July 2026 |
152,746 |
675.2000 |
660.80 |
666.6770 |
BATE |
|
29 July 2026 |
710,534 |
668.0000 |
660.80 |
663.5018 |
LSE |
|
29 July 2026 |
207,519 |
668.0000 |
660.80 |
663.5363 |
CHIX |
|
29 July 2026 |
71,534 |
668.0000 |
660.60 |
663.4922 |
BATE |
|
30 July 2026 |
22,630 |
661.2000 |
659.20 |
659.7263 |
LSE |
|
30 July 2026 |
2,879 |
660.8000 |
660.80 |
660.8000 |
CHIX |
|
|
|
|
|
|
|
|
* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share |
|
||||
|
Such purchases form part of the Company's existing share buyback programme and were effected pursuant to the instructions issued by the Company to UBS on 16 February 2026, as announced on 16 February 2026. |
|||||
|
|
|
|
|
|
|
|
The Company intends to cancel the repurchased Ordinary Shares. |
|
||||
|
|
|
|
|
|
|
|
Following the settlement of the above transactions, NWG will hold 178,743,441 Ordinary Shares in treasury and have 7,959,736,747 Ordinary Shares in issue (excluding treasury shares). The total number of voting rights in the Company will be 31,840,879,548. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. |
|||||
|
|
|
|
|
|
|
|
Further information: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Relations |
|
|
|
|
|
|
+ 44 (0)207 672 1758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Media Relations |
|
|
|
|
|
|
+44 (0)131 523 4205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Legal Entity Identifier: 2138005O9XJIJN4JPN90 |
|
|
|
||
|
|
|
|
|
|
|
|
Transaction details: |
|
|
|
|
|
|
In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programme relating to the Transactions is detailed in the attached: |
|||||
| http://www.rns-pdf.londonstockexchange.com/rns/8536O_1-2026-7-31.pdf
|
|||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Bango
- 2 hours ago Sequoia Economic Infrastructure Income Fund Limited
- 2 hours ago Staffline Group
- 3 hours ago PureTech Health
- 3 hours ago Vesuvius